Specifically, levels of insoluble UFSP2 were significantly associated with Braak stage in the frontal cortex of the control, but not the combined or the AD cohort, while levels of insoluble UFM1 were associated with the Thal stage in the group that contains data from all subjects. The gene discussed is UFSP2; the disease is Alzheimer disease.